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Abstract
Objectives: The purpose of this study was to compare the use of amoxicillin (1g)  vs amoxicillin and clavulanate 
(875/125mg) after extraction of retained third molars for prevention of infectious complications.
Study Design: The study involved 546 patients attending for removal a retained third molar and divided in to two 
groups: Group 1 - amoxicillin and clavunate (875/125mg) group (n=257) and Group 2 - amoxicillin (1g) group 
(n=289). All patients were recalled for investigating the possibility of infection, presence of diarrhea and further 
analgesic intake.
Results: From a total of 546 patients, the frequency of infection was 1.4%, without no statistically differences be-
tween the two groups. Group 1 showed statistically higher presence of patients with gastrointestinal complications 
(p>0.05). In 546 patients, 2.7% of patients reported severe pain that would not relieve with medication. 
Conclusions: The results of our study show that the use of amoxicillin (1g) and amoxicillin and clavunate 
(875/125mg) is similar efficacious in preventing infection after retained third molar extraction but amoxicillin and 
clavunate (875/125mg) produces more gastrointestinal discomfort. 
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Introduction
The extraction of retained third molars is one of the most 
frequently procedures in common practice in dental of-
fices and maxillofacial surgery (1). This type of inter-
vention is classified as a “clean-contaminated surgery.” 
Common complications of the removal of retained third 
molar are pain, swelling, dysphagia and trismus.  How-
ever, they are also relatively frequent infectious com-
plications as alveolitis (2) (20-30%) and surgical wound 
infection (1-6%) (3). Because of these, some authors 
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support the establishment of antibiotic guidelines are 
necessary to prevent from them (3). Nevertheless, an-
tibiotic prophylaxis in third molar surgical removal re-
mains controversial (4,5).
The aim of this study was to assess the influence of the 
use of clavulanate in the post-operatory after the surgi-
cal removal of retained third molar, added to the amoxi-
cillin and, concerning to the obtained results, evaluate 
the viability to incorporate clavunate for prevention of 
infection complications. 
Patient and Methods
The study sample involved patients derived from the 
Virgen del Rocío University Hospital of Seville and 
from the Dental School at the University of Seville that 
fulfill the inclusion criteria: age over 18 years old, no 
allergy to penicillin or drugs used in this study, need 
of surgical removal of a retained third molar and assent 
of informed consent. Patients excluded were pregnant 
women and patients who needed more than 30 minutes 
time surgery. After extraction, subjects were assigned 
and divided in two groups. Group 1 was performed with 
patients who were prescribed amoxicillin and clavunate 
875/125mg every 8 hours for 7 days. Patients who were 
prescribed amoxicillin 1g every 8 hours for 7 days make 
the Group 2. Finally, we conducted a randomized trial 
in 546 patients (Group 1: 257 patients; Group 2: 289 pa-
tients) requiring surgical removal of included third mo-
lars. The groups were comparable from the standpoint 
of position, orientation, impaction and history of peri-
coronitis. The investigation was previously approved by 
the Ethical Committee of the University Hospital. 
After surgery, postoperative instructions were explained 
carefully to all patients and they were only prescribed 
anti-inflammatory and analgesic medication (ibuprofen 
600mg every 8 hours at the most) for postoperative pain 
relief. Oral and written recommendations were given.
On the sixth day patients were request by telephone 
about their condition. Registered variables were:
-Pus. Patients were asked about the presence of purulent 
liquid through the wound or severe halitosis.
-Fever above 38°C after the first 48 hours 
-Pain and relief of pain with anti-inflammatories and 
painkillers, which indicated the possibility of clinical 
diagnosis of alveolitis (2). 
-Inflammation persistent over time that does not im-
prove during the week.
To integrate this different criterion, the infection crite-
rion used in this study is the presence of pus with anoth-
er positive criterion (of previously mentioned) or three 
positive criterion (of previously mentioned).
-Lockjaw or trismus. This criterion was evaluated as the 
inability of the patient to introduce two fingers transver-
sally in their mouth.
-Gastrointestinal upset.
A complete clinical examination and checkup about 
previous described variables was performed on seventh 
day in patients who had any of these first five criteria, to 
confirm the presence of infection.
All data collected were analyzed using the SPSS statis-
tical package. Comparisons between groups were ana-
lyzed using the chi-square test. Statistically differences 
were considered at p<0.05.
Results
The study involved 546 patients, 233 men and 313 wom-
en. The average age of males was 29.04 years and wom-
en 27.93 years. In Group 1, 257 patients (29.12+10.09 
years; 96 males; 161 females) were included and in the 
Group 2, 289 (28.09+8.24 years; 137 males; 152 fe-
males) patients were studied. All patients received a full 
antibiotic treatment as previously was described.
Most of variables studied showed higher frequency in 
amoxicillin (1g) patients (Group 2), except the presence 
of fever above 38°C after the first 48 hours and com-
plaint of gastrointestinal upset (Table 1). 
  Group 1 Group 2 p*
Pus (%) 0.91 1.46 NS 
Fever (%) 1.46 0.73 NS 
Pain (%) 0.55 2.20 <0.05 
Inflammation (%) 1.46 4.76 <0.05 
Infection criterion (%) ** 1.38 1.55 NS 
Trismus (%) 0.55 3.84 <0.05 
Gastrointestinal complications(%) 5.49 0.55 <0.05 
Ibuprofen pills (mean ± SD) 4.04 ± 5.6 3.44 ± 4.2 NS *** 
Table 1. Comparison of presence of registered variables (%) 
and number of ibuprofen pills ((mean ± SD) in amoxicillin and 
clavulanate 875/125mg  (group 1) and amoxicillin 1g (group 2) 
patients. 
*: chi square test
** At least, 3 of 5 previous criterion 
*** For this variable, the results are done in mean and SD of 
number of pill taken (test: t-Student) 
Chi square test was used to compare postoperative 
variables between patients who used amoxicillin (1g) vs 
amoxicillin and clavulanate (875/125mg) after extrac-
tion of third molars. No statistically significant differ-
ences (p>0.05) were found in the presence of pus, fever, 
and relief of pain with other drugs. Statistically differ-
ences were found (p<0.05), in the presence of alveolitis, 
persistence of inflammation, trismus and gastrointes-
tinal complications (Table 1). However, we found no 
statistically significant differences (p>0.05) in the pres-
ence of criterion of infection between the two groups. 
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Discussion
The use of antibiotic prophylaxis is usually in third mo-
lar surgery since it is considered clean-contaminated 
surgery. However the use and the correct use of rou-
tine antibiotic prophylaxis is a controversial topic (6). 
Infectious pathology associated with third molars has 
created the necessity of multiple studies that have been 
carried out with different antibiotics, and whether in-
fection prevention is really necessary or not (7). There 
is no consensus on the antibiotic of choice for prophy-
laxis guidelines (8). Siddigi’s and Zeitler’s research have 
shown that the infection of the surgical wound infection 
rate is low and infrequent, then they do not advise the 
use of antibiotics as routine prevention in the removal of 
third molars (3,9). 
However, many authors suggest that there are significant 
differences of infection in groups of patients who are 
treated with antibiotic therapy compared to those who 
received placebo (10-13). In fact, the results of the well-
done metanalisis by Fang Yang revealed that the use of 
antibiotics improves postoperative complaints of the pa-
tients and reduces the appearance of infection (13).
The most frequently isolated bacteria in odontogenic 
infection are Streptococcus viridans, Peptoestrepto-
coco, Prevotella intermedia, Fusobacterium nucleatum 
and Porphiromona gingivalis (14,15). Kuriyama noted 
in their studies that 7% of these species produced beta-
lactamase, and that production was associated with the 
previous use of beta-lactam antibiotics (16). In order to 
reduce bacterial resistance, clavulanate became associ-
ated with amoxicillin (17). Some researchers have found 
that clindamycin and amoxicillin with clavulanate are 
the most effective antibiotics in established odontogenic 
infection (15).
There is no consensus on the use of antibiotics in the 
extraction of retained third molars, and neither the type 
of antibiotic of choice in case of support it (18-20). Our 
purpose was to study the selection of the correct anti-
biotic for the prevention of infection after the surgical 
removal of third molars as one of the principles of anti-
biotic prophylaxis delineated by Peterson (21). In other 
words, the use or not of clavulanate with amoxicillin. 
We followed-up 546 patients with surgical removal of a 
retained third molar during 7 days. 
In our study we found that amoxicillin produced more 
swelling, trismus and pain (although without statistically 
significant differences) but significant less gastrointes-
tinal discomfort that the combination with clavulante. 
However, amoxicillin (1g) and amoxicillin/clavulanate 
(875/125mg) were equally effective in preventing infec-
tion after third molar extraction. 
Though there is true that all the patients were not exam-
ined and the post-operative screening assessment was 
accomplished by phone greatly, and this detracts from 
the value of the study (for example, it is well know that 
a patient can return with occult purulent drainage that 
will only be discovered with a careful examination), the 
data are so clear that the conclusions are acceptable. 
Our results are in concordance with the literature who 
studied the same parameters in the prevention of in-
fection after the removal of retained third molars. The 
pharmacovigilance group of Italy noted that clavulanate 
had a higher number of complications especially in the 
gastrointestinal system, and even bacteria can also cre-
ate resistance to clavulanate. They conclude that amoxi-
cillin is the antibiotic of choice except in patients with 
severe infections (22). Bresco’s studies concluded that 
the most effective antibiotic in the treatment of odon-
togenic infection was amoxicillin with clavulanate but 
clinical effects are very similar, so it does not make any 
difference between their use (15).
To sum up and after analyzed our results, if there is no 
difference in the prevention of infection after surgical 
removal of retained third molars with amoxicillin of 
amoxicillin/clavulanate and the last one produces sig-
nificant more gastrointestinal discomfort, we conclude 
that the association between clavulanate and amoxicil-
lin is not indicated as routine in guidelines after extrac-
tion of third molars.
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